First experience with the biostar-device for various applications in pediatric patients with congenital heart disease

Catheterization and Cardiovascular Interventions

Volumn 75, Issue 1, 2010, Pages 72-77

  Hoehn, Rene ^a   Hesse, Carola ^a   Ince, Hüseyin ^a   Peuster, Matthias ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

BioSTAR; Patent foramen ovale atrial septal defect; Pediatric interventions; Transeptal cath

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADOLESCENT; ARTICLE; BLEEDING; CHILD; CONGENITAL HEART DISEASE; FLUOROSCOPY; HEART SEPTUM DEFECT; HUMAN; IMPLANT; IMPLANTATION; INFANT; PRESCHOOL CHILD; SCHOOL CHILD; TACHYCARDIA; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; FONTAN PROCEDURE; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HEMODYNAMICS; HUMANS; INFANT; MALE; PROSTHESIS DESIGN; RADIOGRAPHY, INTERVENTIONAL; SEPTAL OCCLUDER DEVICE; TIME FACTORS; TREATMENT OUTCOME;

EID: 74249090830     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22233     Document Type: Article

References (31)

1. Hausdorf G, Kaulitz R, Paul T, Carminati M, Lock J. Transcatheter closure of atrial septal defect with a new flexible, self-centering device (the STARFlex Occluder). Am J Cardiol 1999;84:1113-1116.
2. Kaulitz R, Peuster M, Jux C, Paul T, Hausdorf G. Transcatheter closure of various types of defects within the oval fossa using the double umbrella device (CardioSEAL)-feasibility and echocardiographic follow-up. Cardiol Young 2001;11:214-222.
3. Carminati M, Chessa M, Butera G, Bini RM, Giusti S, Festa P, Spadoni I, Redaelli S, Hausdorf G. Transcatheter closure of atrial septal defects with the STARFlex device: Early results and follow-up. J Interv Cardiol 2001;14:319-324.
4. Büscheck F, Sievert H, Kleber F, Tiefenbacher C, Krumsdorf U, Windecker S, Uhlemann F, Wahr DW. Patent foramen ovale using the premere device: The results of the CLOSEUP trial. J Interv Cardiol 2006;19:328-333.
5. Nugent AW, Britt A, Gauvreau K, Piercey GE, Lock JE, Jenkins KJ. Device closure rates of simple atrial septal defects optimized by the STARFlex device. J Am Coll Cardiol 2006;48:538-544.
6. Billinger K, Ostermayer S, Carminati M, Degiovanni J, Ewert P, Hess J, Maymone-Martins F, Qureshi S, Salmon A, Schneider M, Wilson N, Sievert H. Helex septal occluder for transcatheter closure of patent foramen ovale: multicentre experience. EuroIntervention 2006;1:465-471.
7. Purcell IF, Brecker SJ, Ward DE. Closure of defects of the atrial septum in adults using the Amplatzer device: 100 consecutive patients in a single center. Clin Cardiol 2004;27:509-513.
8. Hijazi ZM. Extracardiac fenestrated fontan operation: To close or not to close the fenestration? Catheter Cardiovasc Interv 2001;54:93-94.
9. Delaney JW, Chan KC, Rhodes JF. The design and deployment of the HELEX septal occluder. Congenit Heart Dis 2006;1: 202-209.
10. Taaffe M, Fischer E, Baranowski A, Majunke N, Heinisch C, Leetz M, Hein R, Bayard Y, Büscheck F, Reschke M, Hoffmann I, Wunderlich N, Wilson N, Sievert H. Am J Cardiol 2008;101:1353-1358.
11. Sherman JM, Hagler DJ, Cetta F. Thrombosis after septal closure device placement: A review of the current literature. Catheter Cardiovasc Interv 2004;63:486-489.
12. Alaeddini J, Feghali G, Jenkins S, Ramee S, White C, Abi-Samra F. Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale. J Invasive Cardiol 2006;18:365-368.
13. Kiblawi FM, Sommer RJ, Levchuck SG. Transcatheter closure of patent foramen ovale in older adults. Catheter Cardiovasc Interv 2006;68:136-142.
14. Hill SL, Berul CI, Patel HT, Rhodes J, Supran SE, Cao QL, Hijazi ZM. Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J Interv Card Electrophysiol 2000;4:469-474.
15. Lai DW, Saver JL, Araujo JA, Reidl M, Tobis J. Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: A case report. Catheter Cardiovasc Interv 2005;66:424-426.
16. Wertman B, Azarbal B, Riedl M, Tobis J. Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. J Am Coll Cardiol 2006;47:1226-1227.
17. Hausdorf G. StarFlex ASD closure: Deployment, techniques, equipment. J Interv Cardiol 2001;14:69-76.
18. Mullen MJ, Hildick-Smith D, De Giovanni JV, Duke C, Hillis WS, Morrison WL,Jux C. BioSTAR Evaluation STudy (BEST): A prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation 2006;114:1962-1967.
19. Jux C, Bertram H, Wohlsein P, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: Development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol 2006;48:161-169.
20. Jux C, Wohlsein P, Bruegmann M, Zutz M, Franzbach B, Bertram H. A new biological matrix for septal occlusion. J Interv Cardiol 2003;16:149-152.
21. Peuster M, Hausdorf G. Reply to the letter to the editor by Lee et al. Catheter Cardiovasc Interv 2001;53:94-95.
22. Peuster M, Kaulitz R, Hausdorf G. A novel method for transcatheter closure of atrial septal defect within an aneurysm of the fossa ovalis: Double sheath technique. Heart 2000;84:e14 (1-2).
23. Hijazi ZM, Fahey JT, Kleinman CS, Kopf GS, Hellenbrand WE. Hemodynamic evaluation before and after closure of fenestrated Fontan: An acute study of changes in oxygen delivery. Circulation 1992;86:196-202.
24. Law MA, Josey J, Justino H, Mullins CE, Ing FF, Nugent AW. Long-term follow-up of the STARFlex device for closure of secundum atrial septal defect. Catheter Cardiovasc Interv 2009;73:190-195.
25. Badylak SF, Tullius R, Kokini K, Shelbourne KD, Klootwyk T, Voytik SL, Kraine MR, Simmons C. The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. J Biomed Mater Res 1995;29:977-985.
26. Badylak SF. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transplant Immunol 2004;12:367-377.
27. Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 2002;13:377-383.
28. Valentin JE, Stewart-Akers AM, Gilbert TW, Badylak SF. Macrophage participation in the degradation and remodeling of ecm scaffolds. Tissue Eng Part A. 2009;15(7):1687-1694.
29. Dua JS, Chessa M, Jones N, Negura D, Micheletti A, Carminati M. Fever after BioSTARVR Implantation: Is it a systemic reaction to the collagen matrix?. J Invasive Cardiol 2009;21:255-255.
30. Krumsdorf U, Horvath K, Ostermayer S, Billinger K, Zadan E, Trepels T, Sievert H. Incidence and clinical outcome of thrombus formation on ASD and PFO closure devices in 900 consecutive patients. Eur Heart J 2002;23(suppl.):129.
31. Jux C, Bertram H. Thrombus formation on intracardiac devices: A complex issue. J Am Coll Cardiol 2004;44:1712-1713.